Beverly, MA – November 23, 2020 – Venture-backed medical technology development company, LeviSense Medical, Inc., is pleased to announce that Dan R. Berlowitz, MD, MPH is joining the board of advisors.

Dan Berlowitz, is a UMass-Lowell Professor at the Zuckerberg College of Health Sciences, Chair of Department of Public Health and Co-Director of The Center of Biomedical and Health Research in Data Sciences (CHORDS).

Dr. Berlowitz has decades of experience as a physician, researcher, educator and administrator. While serving at the Department of Veterans Affairs, he received VA’s Under Secretary’s Award for Outstanding Achievement in Health Services Research. The award is the highest honor given to a VA health services researcher. His research interests center on assessing and improving the quality of medical care in ambulatory and long-term care settings. With strong methodological expertise in the areas of quality assessment, risk adjustment and the use of large databases, his research findings have led to improvements in the management of diverse conditions including uncontrolled hypertension and pressure injuries. He was also a part of the 12-member Guideline Governance Group responsible for the recent publication of the international guideline on the prevention and treatment of pressure injuries.

A prolific author with more than 220 publications, Dr. Berlowitz serves on the Editorial Advisory Board of Advances in Skin & Wound Care and Journal of the American Geriatrics Society.

“My research interests center on assessing and improving the quality of medical care with a particular focus on ambulatory and long-term care settings. My work has examined a variety of clinical conditions with much of the emphasis being on two diseases, hypertension and pressure injuries,” said Dr. Berlowitz.  “There is much testing and research to be done, but the LeviSense surface development could be a significant tool for the health of spinal cord injury patients, a cohort I had a lot of experience with at the VA.”

“Dr. Berlowitz has the experience and scientific background that can help guide us to translate technology to clinical benefits in a variety of healthcare settings,” said Dave Bertoni, LeviSense CEO.